Chronic administration of mood stabilizers upregulates BDNF and bcl-2 expression levels in rat frontal cortex.

Neurochemical Research
Yunyoung C ChangJagadeesh S Rao

Abstract

Brain-derived neurotrophic factor (BDNF) and B-cell lymphoma-2 (Bcl-2) proteins are neuroprotective factors involved in neuronal signaling, survival and plasticity. Both can be regulated by cyclic AMP response element binding (CREB) protein. Decreased levels of BDNF and Bcl-2 are implicated in the pathogenesis of bipolar disorder. The present study investigated whether chronically administered mood stabilizers would increase BDNF and/or Bcl-2 levels in rat brain. Real time RT-PCR, sandwich ELISA and Western blotting were used to measure BDNF and Bcl-2 mRNA and protein levels in the frontal cortex of rats chronically administered carbamazepine (CBZ) or lamotrigine (LTG) to produce plasma concentrations therapeutically relevant to bipolar disorder. Chronic CBZ and LTG significantly increased BDNF and Bcl-2 mRNA and protein levels in the frontal cortex. A common mechanism of action of mood stabilizers in the treatment of bipolar disorder may involve neuroprotection mediated by upregulation of brain BDNF and Bcl-2 expression.

References

May 28, 1996·Proceedings of the National Academy of Sciences of the United States of America·D G TangK V Honn
Jun 25, 1999·Brain Research. Molecular Brain Research·B ChenL T Young
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·W E LyonsL Tessarollo
Oct 18, 2000·Biological Psychiatry·L F JarskogJ A Lieberman
Nov 7, 2000·Biological Psychiatry·R S DumanC D'Sa
Jun 20, 2002·Bipolar Disorders·Grazyna Rajkowska
Jul 2, 2002·Journal of Neurochemistry·Lian MaiXiaohua Li
Dec 20, 2003·Annals of the New York Academy of Sciences·Neil A GrayHusseini K Manji
Jan 2, 2004·The American Journal of Psychiatry·L Fredrik JarskogJohn H Gilmore
Jan 7, 2004·Molecular Psychiatry·Michael B KnableUNKNOWN Stanley Neuropathology Consortium
May 5, 2004·Archives of General Psychiatry·Stephen R DagerPerry F Renshaw
Mar 31, 2005·European Psychiatry : the Journal of the Association of European Psychiatrists·J R CalabreseR L Findling
Apr 14, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jagadeesh S RaoFrancesca Bosetti
Jun 3, 2005·Journal of Neuroscience Research·Kyoung Ja KwonEun Joo Baik
Sep 24, 2005·Annals of the New York Academy of Sciences·De-Maw Chuang
Jan 18, 2006·Bipolar Disorders·In Kyoon LyooPerry F Renshaw
Feb 16, 2006·The Australian and New Zealand Journal of Psychiatry·Brian DeanElizabeth Scarr
Mar 15, 2006·The Journal of Biological Chemistry·Narendra WajapeyeeKumaravel Somasundaram
Apr 20, 2006·The Journal of Biological Chemistry·Elisabeth M ChalovichCharleen T Chu
May 23, 2006·Gene Expression Patterns : GEP·M J WebsterC Shannon Weickert

❮ Previous
Next ❯

Citations

Sep 24, 2013·Toxicology in Vitro : an International Journal Published in Association with BIBRA·Maria I MorteCaetana M Carvalho
Oct 29, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ayşegül YildizRoss J Baldessarini
Jan 19, 2012·Parkinson's Disease·Edward C LauterbachAntonio L Teixeira
Feb 19, 2013·Journal of Psychiatry & Neuroscience : JPN·Joel JakobssonMikael Landén
Mar 13, 2014·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Joseph P Steiner, Avindra Nath
Oct 16, 2015·Journal of Receptor and Signal Transduction Research·Thomas Del' Guidice, Jean-Martin Beaulieu
Jul 4, 2012·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Nicole PagèsJoseph Vamecq
Oct 29, 2011·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Rongju SunTanshi Li
Jun 18, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Annemarie HeberleinThomas Hillemacher
Jun 27, 2009·Brain Research Reviews·Stanley I RapoportJagadeesh S Rao
May 4, 2011·Early Intervention in Psychiatry·Craig A MacneilPhilippe Conus
Sep 26, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Annemarie HeberleinThomas Hillemacher
Apr 10, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ning SongTsukasa Koyama
Feb 7, 2012·Pharmacology, Biochemistry, and Behavior·Helena M AbelairaJoão Quevedo
Feb 23, 2013·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Hye Ji MinDuk-In Jon
Dec 7, 2011·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Sehwan ShimJungkee Kwon
Apr 18, 2012·Progress in Neuro-psychopharmacology & Biological Psychiatry·Edward C Lauterbach
Jul 8, 2011·The International Journal of Neuropsychopharmacology·Epolia RamadanStanley I Rapoport
May 12, 2012·The International Journal of Neuropsychopharmacology·María ReinaresEduard Vieta
Sep 18, 2010·The International Journal of Neuropsychopharmacology·Nanxin LiShuchang He
Jan 13, 2010·Free Radical Biology & Medicine·Marco AssunçãoJosé P Andrade
Jun 20, 2012·The Australian and New Zealand Journal of Psychiatry·Andrew A NierenbergDan V Iosifescu
Apr 30, 2017·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·Rituparna MaitiDebasis Bisoi
Sep 9, 2010·Journal of Psychopharmacology·Benedikt AmannPeter McKenna

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.